Why did PHRX.CN stock spike today?

PHRX.CN stock rose on renewed interest in its psychedelics pipeline and research agreements. The move occurred on limited volume relative to the 50-day average, suggesting speculative or news-driven trading rather than broad institutional buying.

What are the key fundamentals for PHRX.CN stock?

Key fundamentals: market cap **C$1,623,516.00**, EPS **-0.01**, PE **-1.50**, book value per share **-0.0139**, and current ratio **0.01**. These show small scale, negative equity and tight liquidity.

What is the short-term forecast for PHRX.CN stock?

Meyka AI's forecast projects a quarterly target of **C$0.02**, implying **33.33%** upside from the current **C$0.015** price. Forecasts are projections and not guarantees.

How should traders manage risk with PHRX.CN stock?

Manage risk by limiting position size given thin liquidity, using tight stops, and watching volume for confirmation. PHRX.CN stock can move sharply on news or low-volume flows.

CA Stocks

PHRX.CN Pharmadrug Inc. (CNQ) rises 50% in market hours: watch volume for follow-through

ByHuzaifa Zahoor February 10, 2026

PHRX.CN stock rose 50.00% to C$0.015 during market hours on 10 Feb 2026 on above-average activity, marking it among today’s top gainers on the CNQ exchange in Canada. The intraday range ran from C$0.01 to C$0.015, with 19,428.00 shares traded versus a 50-day average of 46,944.00. Investors reacted to renewed interest in the company’s psychedelics and natural-medicines pipeline alongside existing research ties to the University of Michigan and Johns Hopkins. This note breaks down the move, fundamentals, technicals, a Meyka AI grade, and a short-term forecast to help frame risk and potential follow-through.